Gajendra Sanjay 4

What Happened
Gajendra Sanjay, President, Chief Operating Officer and a director of Astera Labs (ALAB), sold a total of 280,000 shares on May 19, 2026 in multiple open‑market transactions, generating aggregate proceeds of approximately $69,774,015. The sales were executed under a pre‑arranged Rule 10b5‑1 trading plan adopted December 2, 2025.

Key Details

• Transaction date: 2026-05-19; Form 4 filed: 2026-05-21 (no late filing indicated in provided data).
• Sales (each line shows shares / weighted-average price / proceeds):
  • 102,839 shares @ $248.91 = $25,597,913 (prices ranged $248.40–$249.395; F2/F7 notes apply)
  • 76,702 shares @ $249.79 = $19,159,500 (prices ranged $249.40–$250.39; F4)
  • 17,847 shares @ $250.75 = $4,475,066 (prices ranged $250.40–$251.23; F5)
  • 2,612 shares @ $251.54 = $657,032 (prices ranged $251.41–$251.80; F6)
  • 40,000 shares @ $248.62 = $9,944,704 (prices ranged $248.40–$249.12; F7)
  • 40,000 shares @ $248.50 = $9,939,800
• Total: 280,000 shares sold for ~$69.8M.
• Notable footnotes: F1 confirms sales were automatic under a 10b5‑1 plan; F2–F7 explain that reported prices are weighted averages and give per‑tranche price ranges; F3, F8 and F9 note certain shares are held in estate‑planning trusts (Reporting Person disclaims beneficial ownership of those trust‑owned shares).
• Shares owned after the transaction: not disclosed in the excerpt provided.

Context
These were sales, not purchases. Sales executed under a 10b5‑1 plan are typically pre‑arranged and automated, which can indicate routine liquidity rather than a change in the insider’s view of the company; do not infer motivation from the transaction alone. For retail investors, purchases by insiders often carry more direct informational weight than routine sales, though large sales can still be relevant for position sizing or timeline analysis.